ClinicalTrials.Veeva

Menu

Does MiECC Improve Outcome in Diabetic Patients Undergoing Elective Coronary Bypass Grafting?

H

Herzzentrum Coswig

Status

Completed

Conditions

Acute Kidney Injury

Treatments

Device: Conventional extracorporeal circulation (CECC)
Device: Minimally invasive extracorporeal circulation (MiECC)

Study type

Interventional

Funder types

Other

Identifiers

NCT02672514
Rölig Studie

Details and patient eligibility

About

The aim of this study was to prospectively evaluate MECC compared with conventional extracorporeal circulation of diabetic patients undergoing elective coronary revascularization procedures. The investigators focused on the effects of extracorporeal circulation especially the renal function between both groups.

Full description

Cardiopulmonary bypass (CPB) is known having a negative influence referring to systemic inflammatory reaction after cardiac surgery which can cause acute kidney injury (AKI). Miniaturized extracorporeal circulation (MECC) attempts to reduce the adverse effects of conventional extracorporeal circulation bypass. Finally, AKI after CPB is a significant clinical problem that increasingly complicates the course of hospitalization and clinical outcome.

Enrollment

104 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diabetes mellitus type 2
  • isolated elective coronary revascularization

Exclusion criteria

  • urgent or emergent Status
  • Re-Operation
  • preexisting reanimation
  • preexisting renal transplantation
  • chronic kidney insufficiency (GFR < 30 ml/min)
  • renal cell carcinoma
  • renal artery Stenosis
  • heart valve disease (middle- and high-grade)
  • endocarditis
  • infections (HIV, Tbc and all types of Hepatitis)
  • hepatic cirrhosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

104 participants in 2 patient groups

MiECC
Active Comparator group
Description:
Coronary artery bypass grafting is used with the help of cardiopulmonary bypass (CPB). The technique used in this arm based on the minimally invasive extracorporeal circulation system (MiECC). MiECC has been developed based on the concept of a closed total CPB circuit. The basic elements are a centrifugal pump, a membrane oxygenator and an arterial filter. The priming volume compared to CECC could be reduced. The complete circuit is heparin-coated for maximizing the biocompatibility. CPB was performed under normothermic conditions of 36°C. Retrograde autologous priming was performed for all patients with stable hemodynamic circulation.
Treatment:
Device: Minimally invasive extracorporeal circulation (MiECC)
CECC
Active Comparator group
Description:
Coronary artery bypass grafting is used with the help of cardiopulmonary bypass (CPB). The technique used in this arm based on the conventional extracorporeal circulation system (CECC). The CECC is an opened circulation system. The basic elements are a membrane oxygenator, a centrifugal pump, an open perfusion system containing the venous hard shell cardiotomy reservoir and the arterial line filter. CPB was performed under normothermic conditions of 36°C. Retrograde autologous priming was performed for all patients with stable hemodynamic circulation, leading to a reduction of the priming volume. The CECC flow was set as required in order to maintain a mean arterial pressure (MAP) between 50 and 75 mmHg.
Treatment:
Device: Conventional extracorporeal circulation (CECC)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems